SEMAGLUTIDE INJECTION
US$ 22.42
3rd generation glp 1 agonist third Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Targeting GLP-1, GIP & GCG
Description
Ahrn, B., Gomis, R., Standl, E., Mills, D
[DOI] [PubMed] [Google Scholar] 180
Darren K
PMID: 22215523
Other, rare side effects associated with taking these drugs include gallstones, pancreatitis, and more severe gastrointestinal problems, such as bowel obstruction or gastroparesis (in which the muscles in the stomach are partially paralyzed and dont move properly for digestion)
